Automated parenteral chemotherapy dose-banding to improve patient safety and decrease drug costs.
J Oncol Pharm Pract
; 26(2): 345-350, 2020 Mar.
Article
em En
| MEDLINE
| ID: mdl-31046608
ABSTRACT
PURPOSE:
To improve patient safety and reduce drug waste through implementation of automated parenteral chemotherapy dose-banding within an electronic health record.METHODS:
Parenteral chemotherapy dose-rounding practices were transitioned from a manual, pharmacist-driven workflow to an automated process within the electronic health record. Initial medications transitioned included bevacizumab, rituximab, and trastuzumab. Dose-banding tables were built to standardize rounding within a 10% parameter and then subsequently incorporated into the electronic health record after receiving multidisciplinary approval. Following implementation, a retrospective chart review was performed to compare drug and associated cost savings with manual dose-rounding and automated dose-banding. Medication safety improvements were measured by comparing the change in the number of clicks needed for pharmacist verification as well as by evaluation of submissions to our event reporting system.RESULTS:
After implementing automated parenteral chemotherapy dose-banding, reported medication errors associated with the parenteral chemotherapy rounding process decreased. The number of event submissions related to incorrect rounding decreased from four submissions in the pre-implementation period to zero in the post-implementation period. Automation saved pharmacists at least 9,297 additional clicks and 11,363 additional keystrokes and also led to notable increases in total drug savings as well as drug cost savings.CONCLUSION:
Overall safety of our parenteral chemotherapy ordering processes within our electronic health record was improved after the implementation of automated dose-banding. By standardizing the administered doses for three chemotherapy agents, we were also able to increase total drug savings and associated drug cost savings.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Farmacêuticos
/
Erros de Medicação
/
Antineoplásicos
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Estados Unidos